| Preface |
|
vii | |
| Note Bene |
|
x | |
| Contributors |
|
xi | |
| Abbreviations |
|
xviii | |
| SECTION I. Health Appraisal, Risk Assessment, and Safety of Exercise |
|
1 | (32) |
|
Benefits and Risks Associated with exercise |
|
|
3 | (19) |
|
Public Health Perspective |
|
|
3 | (2) |
|
Benefits of Regular Physical Activity and/or Exercise |
|
|
5 | (1) |
|
Risks Associated With Exercise Testing |
|
|
6 | (4) |
|
Risks Associated With Vigorous Exercise |
|
|
10 | (12) |
|
Incidence of Cardiovascular Complications |
|
|
12 | (1) |
|
Issues Regarding Preliminary Screening |
|
|
13 | (2) |
|
Recommendations to Reduce the Incidence and Severity of Complications During Exercise |
|
|
15 | (7) |
|
Health Screening and Risk Stratification |
|
|
22 | (11) |
|
Preparticipation Health Screening |
|
|
22 | (3) |
|
|
|
25 | (2) |
|
Risk Stratification for Cardiac Patients |
|
|
27 | (6) |
|
Modifying Coronary Risk Status |
|
|
29 | (4) |
| SECTION II. Exercise Testing |
|
33 | (102) |
|
Pretest Clinical Evaluation |
|
|
35 | (22) |
|
Medical History, Physical Examination, and Laboratory Tests |
|
|
35 | (15) |
|
|
|
37 | (2) |
|
|
|
39 | (1) |
|
Cholesterol and Lipoproteins |
|
|
39 | (2) |
|
|
|
41 | (2) |
|
|
|
43 | (7) |
|
Contraindications to Exercise Testing |
|
|
50 | (1) |
|
|
|
51 | (6) |
|
|
|
52 | (5) |
|
Physical Fitness Testing and Interpretation |
|
|
57 | (34) |
|
Purposes of Fitness Testing |
|
|
57 | (1) |
|
Basic Principles and Guidelines |
|
|
58 | (1) |
|
|
|
58 | (1) |
|
|
|
59 | (1) |
|
|
|
59 | (1) |
|
|
|
59 | (9) |
|
|
|
60 | (2) |
|
|
|
62 | (2) |
|
|
|
64 | (4) |
|
Cardiorespiratory Fitness |
|
|
68 | (12) |
|
The Concept of Maximal Oxygen Uptake |
|
|
68 | (1) |
|
Maximal versus Submaximal Exercise Testing |
|
|
69 | (1) |
|
|
|
70 | (7) |
|
Cardiorespiratory Test Sequence and Measures |
|
|
77 | (3) |
|
Test Termination Criteria |
|
|
80 | (1) |
|
|
|
80 | (5) |
|
|
|
85 | (6) |
|
Clinical Exercise Testing |
|
|
91 | (24) |
|
Indications and Applications |
|
|
91 | (4) |
|
Diagnostic Exercise Testing |
|
|
91 | (2) |
|
Exercise Testing for Disease Severity and Prognosis |
|
|
93 | (1) |
|
Exercise Testing After Myocardial Infarction |
|
|
93 | (1) |
|
Functional Exercise Testing |
|
|
93 | (2) |
|
|
|
95 | (2) |
|
|
|
97 | (2) |
|
Upper Body Exercise Testing |
|
|
98 | (1) |
|
Testing for Return to Work |
|
|
99 | (2) |
|
|
|
100 | (1) |
|
|
|
101 | (1) |
|
|
|
101 | (5) |
|
Heart Rate and Blood Pressure |
|
|
102 | (1) |
|
|
|
103 | (2) |
|
Electrocardiographic Monitoring |
|
|
105 | (1) |
|
|
|
105 | (1) |
|
|
|
106 | (1) |
|
Indications for Exercise Test Termination |
|
|
106 | (1) |
|
Exercise Testing With Imaging Modalities |
|
|
107 | (2) |
|
Exercise Echocardiography |
|
|
107 | (1) |
|
|
|
107 | (1) |
|
Pharmacologic Stress Testing |
|
|
108 | (1) |
|
Considerations for Pulmonary Patients |
|
|
109 | (2) |
|
|
|
109 | (1) |
|
Exercise Testing of Pulmonary Patients |
|
|
110 | (1) |
|
Supervision of Exercise Stress Testing |
|
|
111 | (4) |
|
Considerations Regarding Medical Supervision |
|
|
111 | (1) |
|
Current Guidelines and Practices |
|
|
111 | (1) |
|
Competency Considerations |
|
|
112 | (1) |
|
Implications for Cost-Effectiveness |
|
|
113 | (2) |
|
Interpretation of Clinical Test Data |
|
|
115 | (20) |
|
Exercise Testing as a Screening Tool for Coronary Artery Disease |
|
|
115 | (1) |
|
Interpretation of Responses to Graded Exercise Testing |
|
|
116 | (8) |
|
|
|
117 | (1) |
|
|
|
117 | (1) |
|
|
|
117 | (3) |
|
|
|
120 | (4) |
|
|
|
124 | (1) |
|
Diagnostic Value of Exercise Testing |
|
|
124 | (6) |
|
|
|
125 | (1) |
|
|
|
126 | (1) |
|
|
|
126 | (1) |
|
Comparison With Imaging Stress Tests |
|
|
127 | (2) |
|
Prognostic Applications of the Exercise Test |
|
|
129 | (1) |
|
Interpretation of Exercise Tests in Pulmonary Patients |
|
|
130 | (5) |
|
Specific Respiratory Diseases |
|
|
130 | (5) |
| SECTION III. Exercise Prescription |
|
135 | (100) |
|
General Principles of Exercise Prescription |
|
|
137 | (28) |
|
|
|
138 | (1) |
|
Overview of the Exercise Prescription |
|
|
139 | (1) |
|
The Art of Exercise Prescription |
|
|
139 | (1) |
|
Components of the Training Session |
|
|
140 | (3) |
|
|
|
141 | (1) |
|
|
|
142 | (1) |
|
|
|
142 | (1) |
|
|
|
143 | (1) |
|
Cardiorespiratory Fitness |
|
|
143 | (8) |
|
|
|
143 | (2) |
|
|
|
145 | (5) |
|
|
|
150 | (1) |
|
|
|
151 | (1) |
|
|
|
151 | (3) |
|
|
|
154 | (2) |
|
Initial Conditioning Stage |
|
|
154 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
156 | (1) |
|
Musculoskeletal Flexibility |
|
|
156 | (3) |
|
|
|
159 | (1) |
|
Maintenance of the Training Effect |
|
|
160 | (1) |
|
|
|
161 | (4) |
|
Exercise Prescription for Cardiac Patients |
|
|
165 | (35) |
|
|
|
166 | (3) |
|
|
|
169 | (6) |
|
|
|
170 | (1) |
|
|
|
171 | (1) |
|
|
|
172 | (1) |
|
Outpatient Rate of Progression |
|
|
172 | (2) |
|
Types of Outpatient Programs |
|
|
174 | (1) |
|
Exercise Prescription Without a Preliminary Exercise Test |
|
|
175 | (1) |
|
|
|
176 | (5) |
|
Eligibility and Exclusion Criteria |
|
|
177 | (1) |
|
Time Course to Resistance Training |
|
|
178 | (1) |
|
|
|
178 | (3) |
|
Arm Exercise Prescription |
|
|
181 | (1) |
|
Arm Exercise Training Heart Rate |
|
|
181 | (1) |
|
Work Rates for Arm Training |
|
|
181 | (1) |
|
Arm Exercise Equipment and Training Modalities |
|
|
182 | (1) |
|
Exercise Training for Return to Work |
|
|
182 | (1) |
|
Optimal Exercise Dosage? Pathophysiologic Considerations |
|
|
183 | (2) |
|
Special Patient Populations |
|
|
185 | (8) |
|
Angina or Silent Ischemia |
|
|
185 | (1) |
|
|
|
186 | (3) |
|
Pacemaker and Implantable Cardioverter Defibrillators |
|
|
189 | (2) |
|
|
|
191 | (2) |
|
Exercise: An Integral Component of a Comprehensive Treatment Approach |
|
|
193 | (7) |
|
Exercise Prescription for Pulmonary Patients |
|
|
200 | (6) |
|
|
|
200 | (2) |
|
|
|
200 | (1) |
|
|
|
200 | (1) |
|
|
|
201 | (1) |
|
|
|
201 | (1) |
|
|
|
202 | (1) |
|
|
|
202 | (1) |
|
|
|
202 | (1) |
|
Alternative Modes of Exercise Training |
|
|
202 | (2) |
|
Continuous Positive Airway Pressure |
|
|
203 | (1) |
|
Upper Body Resistance Training |
|
|
203 | (1) |
|
Ventilatory Muscle Training |
|
|
203 | (1) |
|
Program Design and Supervision |
|
|
204 | (2) |
|
Monitoring Exercise Training Intensity |
|
|
204 | (2) |
|
Other Clinical Conditions Influencing Exercise Prescription |
|
|
206 | (11) |
|
|
|
206 | (2) |
|
Lower-Extremity Peripheral Vascular Disease |
|
|
208 | (4) |
|
|
|
212 | (2) |
|
|
|
214 | (3) |
|
Programs for Reducing Body Fatness |
|
|
214 | (3) |
|
Exercise Testing and Prescription for Children, the Elderly, and Pregnant Women |
|
|
217 | (18) |
|
|
|
217 | (6) |
|
|
|
217 | (1) |
|
Clinical Exercise Testing |
|
|
218 | (1) |
|
|
|
219 | (4) |
|
|
|
223 | (7) |
|
|
|
223 | (2) |
|
|
|
225 | (5) |
|
|
|
230 | (5) |
| SECTION IV. Special Considerations |
|
235 | (36) |
|
Methods for Changing Exercising Behaviors |
|
|
237 | (21) |
|
|
|
237 | (2) |
|
|
|
239 | (2) |
|
Psychological Components of Successful Behavior Change |
|
|
241 | (1) |
|
Strategies to Improve Behavioral Change Outcomes |
|
|
242 | (7) |
|
Practical Recommendations to Enhance Exercise Adherence |
|
|
245 | (4) |
|
Population-Specific Barriers to Physical Activity |
|
|
249 | (1) |
|
Program Models: Group versus Home-Based Exercise Therapy |
|
|
249 | (2) |
|
Other Targets for Health Behavior Change |
|
|
251 | (7) |
|
|
|
252 | (1) |
|
|
|
252 | (1) |
|
|
|
253 | (1) |
|
|
|
254 | (4) |
|
|
|
258 | (13) |
|
Contracts, Informed Consent, and Torts |
|
|
259 | (2) |
|
|
|
259 | (1) |
|
|
|
260 | (1) |
|
|
|
261 | (1) |
|
Negligence and/or Malpractice |
|
|
261 | (3) |
|
Defenses to Negligence and/or Malpractice Actions |
|
|
263 | (1) |
|
|
|
264 | (1) |
|
|
|
264 | (3) |
|
Policies, Protocols, Forms, and Fulfillment |
|
|
266 | (1) |
|
Legal Concerns and the Roles of Licensed and Nonlicensed Exercise Professionals |
|
|
267 | (2) |
|
|
|
269 | (2) |
| SECTION V. Appendices |
|
271 | (82) |
|
Appendix A. Common Medications |
|
|
273 | (10) |
|
Appendix B. Emergency Management |
|
|
283 | (10) |
|
Appendix C. Electrocardiogram (ECG) Interpretation |
|
|
293 | (7) |
|
Appendix D. Metabolic Calculations |
|
|
300 | (13) |
|
Appendix E. Environmental Considerations |
|
|
313 | (9) |
|
Appendix F. American College of Sports Medicine Certifications |
|
|
322 | (31) |
| Index |
|
353 | |